Literature DB >> 15289324

Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.

Albana Gattelli1, María Cecilia Cirio, Ana Quaglino, Carolina Schere-Levy, Natalia Martinez, María Binaghi, Roberto P Meiss, Lucio H Castilla, Edith C Kordon.   

Abstract

Mouse mammary tumor virus (LA) induces pregnancy-dependent mammary tumors that progress toward autonomy. Here we show that in virgin females, pregnancy-dependent tumor transplants are able to remain dormant for up to 300 days. During that period, these tumors synthesize DNA, express high levels of estrogen and progesterone receptors (ER+PR+) and are able to resume growth after hormone stimulation. Surprisingly, in a subsequent transplant generation, all these tumors are fully able to grow in virgin females, they express low levels of ER and PR (ER-PR-) and have a monoclonal origin; i.e., show all of the features we have described previously in pregnancy-independent tumors. Histologically, mouse mammary tumor virus (LA)-induced tumors are morphologically similar to genetically engineered mouse (GEM) mammary tumors that overexpress genes belonging to the Wnt pathway. Interestingly, in the virus-induced neoplasias, pregnancy-independent passages arising after a dormant phase usually display a lower level of glandular differentiation together with epithelial cell trans-differentiation, a specific feature associated to Wnt pathway activation. In addition, dormancy can lead to the specific selection of Int2/Fgf3 mutated and overexpressing cells. Therefore, our results indicate that during hormone-dependent tumor dormancy, relevant changes in cell population occur, allowing rapid progression after changes in the animal internal milieu.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289324     DOI: 10.1158/0008-5472.CAN-03-3992

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines.

Authors:  Albana Gattelli; María N Zimberlin; Roberto P Meiss; Lucio H Castilla; Edith C Kordon
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background.

Authors:  Hui-Chuan Sun; Zhao-You Tang; Zeng-Chen Ma; Lun-Xiu Qin; Lu Wang; Qin-Hai Ye; Jia Fan; Zhi-Quan Wu; Xin-Da Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-21       Impact factor: 4.553

Review 3.  MMTV-induced pregnancy-dependent mammary tumors : early history and new perspectives.

Authors:  Edith C Kordon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

Review 4.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

Review 5.  The role of metastasis suppressor genes in metastatic dormancy.

Authors:  Christine E Horak; Jong Heun Lee; Jean-Claude Marshall; S Martin Shreeve; Patricia S Steeg
Journal:  APMIS       Date:  2008 Jul-Aug       Impact factor: 3.205

Review 6.  Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge.

Authors:  Grace G Bushnell; Abhijeet P Deshmukh; Petra den Hollander; Ming Luo; Rama Soundararajan; Dongya Jia; Herbert Levine; Sendurai A Mani; Max S Wicha
Journal:  NPJ Breast Cancer       Date:  2021-05-28

Review 7.  Autophagy and Cancer Dormancy.

Authors:  Yunus Akkoc; Nesibe Peker; Arzu Akcay; Devrim Gozuacik
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

8.  Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling.

Authors:  Ana Quaglino; Carolina Schere-Levy; Leonardo Romorini; Roberto P Meiss; Edith C Kordon
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  A mouse model for luminal epithelial like ER positive subtype of human breast cancer.

Authors:  M J Mahesh Kumar; K S Ponvijay; R Nandhini; R S Nagarajan; J Jose; G Srinivas; P Nagarajan; R Venkatesan; Kishor Kumar; S Singh
Journal:  BMC Cancer       Date:  2007-09-20       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.